Draper
hybrid fundWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
The evidence references Draper's longevity investment thesis, describing longevity as a convergence of biotech and data infrastructure. OpenDrugs sits directly in that intersection as AI-native longevity data infrastructure with drug-discovery relevance.